Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- Mylan Technologies Inc.
- Target Recruit Count
- 1319
- Registration Number
- NCT05139121
- Locations
- 🇺🇸
Medisense Inc., Atlanta, Georgia, United States
🇺🇸Agile Clinical Research Trials, Atlanta, Georgia, United States
🇺🇸University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath